|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| A61P 11/00 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2496249 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10828932.3 |
| Europos patento paraiškos padavimo data | 2010-10-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/054553 |
| Data | 2010-10-28 |
| (87) | Numeris | WO 2011/056713 |
| Data | 2011-05-12 |
| (30) | Numeris | Data | Šalis |
| 257603 P | 2009-11-03 | US |
| (72) |
VAN CAUTER, Eve, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
Amylin Pharmaceuticals, LLC, 1800 Concord Pike, Wilmington, DE 19850, US |
| (54) | GLP-1 RECEPTOR AGONIST FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA |
| GLP-1 RECEPTOR AGONIST FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA |